Designing A Better Future For Immuno-Oncology: The Power Of ‘Iterative Innovation’
Insights From Peter Sandor, Primary Focus Lead IO, Astellas Pharma
We are at a pivotal point in the reassessment of our approach to innovation, with the value of ‘design thinking’ and an ‘iterative innovation approach’ becoming the most promising solutions to solving the scientific and biological challenges of the future.
